208 related articles for article (PubMed ID: 757692)
1. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
Bendre AR; Gangal SG
Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
[No Abstract] [Full Text] [Related]
2. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. I. Adaptation of the virus to mouse tumour cells as a pre-requisit for adjuvanticity.
Bendre AR; Gangal SG
Indian J Cancer; 1978 Dec; 15(4):1-8. PubMed ID: 757683
[No Abstract] [Full Text] [Related]
3. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
4. Specific rejection and regression of solid tumour by tumour extract.
Menon IR; Batra BK; Raveendran P
Indian J Med Res; 1974 Jul; 62(7):1032-8. PubMed ID: 4435913
[No Abstract] [Full Text] [Related]
5. Immunologic enhancement in a syngeneic tumor system.
Beltz WR; Levy NL
Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
[No Abstract] [Full Text] [Related]
6. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
7. The specificity of concomitant tumor immunity at large tumor volumes.
Deckers PJ; Pardridge DH; Wang BS; Mannick JA
Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
[TBL] [Abstract][Full Text] [Related]
8. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene.
Ménard S; Colnaghi MI; Della Porta G
Cancer Res; 1973 Mar; 33(3):478-81. PubMed ID: 4689897
[No Abstract] [Full Text] [Related]
9. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
Rouse BT; Wagner H; Harris AW
J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
[No Abstract] [Full Text] [Related]
10. Radiocurability of a transplantable murine sarcoma as influenced by immune competence of the host and adjuvant active specific immunotherapy.
Deneufbourg JM
Strahlentherapie; 1975 Apr; 149(4):457-62. PubMed ID: 237344
[TBL] [Abstract][Full Text] [Related]
11. Rat tumour allografts evoke anaphylactic antibody responses.
Broom BC; Alexander P
Immunology; 1975 Jun; 28(6):1033-40. PubMed ID: 48504
[TBL] [Abstract][Full Text] [Related]
12. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
[No Abstract] [Full Text] [Related]
13. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
Jurin M; Suit HD
Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
[No Abstract] [Full Text] [Related]
14. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
Edelman AS; Xue B; Sanchez P; Thorbecke GJ
J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of immunological enhancement.
Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
[No Abstract] [Full Text] [Related]
16. Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft.
Zola H
Clin Exp Immunol; 1972 Aug; 11(4):585-93. PubMed ID: 4563711
[TBL] [Abstract][Full Text] [Related]
17. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
[No Abstract] [Full Text] [Related]
18. Migration inhibition of immune mouse spleen cells by from X-irradiated tumor-bearing mice.
Moroson H
Radiat Res; 1978 Jan; 73(1):192-200. PubMed ID: 622459
[No Abstract] [Full Text] [Related]
19. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
Weissman IL
J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
[No Abstract] [Full Text] [Related]
20. The role of adherent cells in tumor immunity.
Burk MW; Yu S; McKhann CF
Surg Forum; 1975; 26():140-2. PubMed ID: 1216090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
